EFFICACY AND SAFETY OF INNOVATIVE SUNSCREEN (E) -4- (TERT-BUTYL) -N '- ((E) -3- (4-METHOXYPHENYL) ALLYLIDENE) BENZIDRAZIDA (TBMAB)

Detalhes bibliográficos
Autor(a) principal: Reis Junior, Mauricio Alexandre
Data de Publicação: 2021
Outros Autores: Santa Rosa, Bruna, de Santana Reis, Juliana, Antônio Corrêa, Marcos, Galdorfini Chiari-Andréo, Bruna, dos Santos, Jean Leandro, Borges Isaac, Vera Lucia
Tipo de documento: Artigo
Idioma: por
Título da fonte: Revista Brasileira Multidisciplinar
Texto Completo: http://revistarebram.com/index.php/revistauniara/article/view/764
Resumo: The constant or repeated unprotected exposure to solar radiation can result in the onset of various harmful effects, such as inflammation, genetic mutation and hyperpigmentation, even than previous photoaging. The use of photoprotective formulations is one of the most effective tools to avoid this. However, most of the UV filters are unstable to UV radiation, can even permeate the skin and cause hepatotoxic effects. The aim of this study was to assess the efficacy and safety of a innovative sunscreen substance (E) -4- (tert-butyl) -N '- ((E) -3- (4-methoxyphenyl) allylidene) benzhydrazide. Methodology: The sunscreen formulation containing the innovative substance was subjected to various stress conditions: 45±2° C, 5±2° C and exposure to sunlight. These samples were evaluated in relation to its rheology, pH, viscosity, density and SPF to determine its stability. The assessment of TBMAB release from the formulation was performed in Microette equipment. Hepatoma cells (HepG2) were used to determine the TBMAB cytotoxicity. Results and Discussion: In the stability study, no significant changes were observed in the formulation. The maximum concentration of TBMAB released from the formulation was 3.63 µg.cm-2. Also, it was evident the cytotoxic effect on the concentrations well above 3.63 µg.cm-2,displaying the safety of this substance, considering HepG2 cells. Conclusion: These results demonstrate that TBMAB is a suitable innovative substance to be used in suscreens, exhibiting stability, desired SPF value and safety, considering HepG2 cells. Thus, it could be a new alternative to prevent skin cancer.  
id UNIARA_59e4a6935a796154b17ac47784644cf5
oai_identifier_str oai:ojs.revistarebram.com:article/764
network_acronym_str UNIARA
network_name_str Revista Brasileira Multidisciplinar
repository_id_str
spelling EFFICACY AND SAFETY OF INNOVATIVE SUNSCREEN (E) -4- (TERT-BUTYL) -N '- ((E) -3- (4-METHOXYPHENYL) ALLYLIDENE) BENZIDRAZIDA (TBMAB)Efficacy and safety of innovative sunscreen (e) -4- (tert-butyl) -n '- ((e) -3- (4-methoxyphenyl) allylidene) benzidrazida (TBMAB)skin cancercytotoxicityUV filterssunscreen.The constant or repeated unprotected exposure to solar radiation can result in the onset of various harmful effects, such as inflammation, genetic mutation and hyperpigmentation, even than previous photoaging. The use of photoprotective formulations is one of the most effective tools to avoid this. However, most of the UV filters are unstable to UV radiation, can even permeate the skin and cause hepatotoxic effects. The aim of this study was to assess the efficacy and safety of a innovative sunscreen substance (E) -4- (tert-butyl) -N '- ((E) -3- (4-methoxyphenyl) allylidene) benzhydrazide. Methodology: The sunscreen formulation containing the innovative substance was subjected to various stress conditions: 45±2° C, 5±2° C and exposure to sunlight. These samples were evaluated in relation to its rheology, pH, viscosity, density and SPF to determine its stability. The assessment of TBMAB release from the formulation was performed in Microette equipment. Hepatoma cells (HepG2) were used to determine the TBMAB cytotoxicity. Results and Discussion: In the stability study, no significant changes were observed in the formulation. The maximum concentration of TBMAB released from the formulation was 3.63 µg.cm-2. Also, it was evident the cytotoxic effect on the concentrations well above 3.63 µg.cm-2,displaying the safety of this substance, considering HepG2 cells. Conclusion: These results demonstrate that TBMAB is a suitable innovative substance to be used in suscreens, exhibiting stability, desired SPF value and safety, considering HepG2 cells. Thus, it could be a new alternative to prevent skin cancer.  A exposição constante e/ou repetida e desprotegida à radiação solar pode resultar no aparecimento de vários efeitos nocivos, como inflamação, mutação genética e hiperpigmentação, mesmo que o fotoenvelhecimento. O uso de formulações fotoprotetoras é uma das ferramentas mais eficazes para evitar isso. No entanto, a maioria dos filtros UV é instável à radiação UV, pode até permear a pele e causar efeitos hepatotóxicos. O objetivo deste estudo foi avaliar a eficácia e a segurança de uma substância protetora solar inovadora (E) -4- (terc-butil) -N '- ((E) -3- (4-metoxifenil) alilideno) benzidrazida. Métodos: A formulação de filtro solar contendo a substância inovadora foi submetida a várias condições de estresse: 45 ± 2°C, 5 ± 2°C e exposição à luz solar. Essas amostras foram avaliadas em relação à sua reologia, pH, viscosidade, densidade e FPS para determinar sua estabilidade. A avaliação da liberação de TBMAB à partir da formulação foi realizada em equipamentos Microette. As células de hepatoma (HepG2) foram usadas para determinar a citotoxicidade do TBMAB. Resultados e Discussão: No estudo de estabilidade, não foram observadas alterações significativas na formulação. A concentração máxima de TBMAB liberada a partir da formulação foi de 3.63 µg.cm-2. Também ficou evidente o efeito citotóxico nas concentrações bem acima de 3.63 µg.cm-2, demonstrando a segurança dessa substância, considerando as células HepG2. Conclusão: Esses resultados demonstram que o TBMAB é uma substância inovadora adequada para ser usada na fotoproteção, exibindo estabilidade, valor desejado de SPF e segurança, considerando as células HepG2. Assim, poderia ser uma nova alternativa para prevenir o câncer de pele.Revista Brasileira Multidisciplinar - ReBraM2021-01-10info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttp://revistarebram.com/index.php/revistauniara/article/view/76410.25061/2527-2675/ReBraM/2021.v24i1.764Revista Brasileira Multidisciplinar - ReBraM; v. 24 n. 1 (2021): Janeiro-Abril; 22-322527-26751415-3580reponame:Revista Brasileira Multidisciplinarinstname:Universidade de Araraquara (UNIARA)instacron:UNIARAporhttp://revistarebram.com/index.php/revistauniara/article/view/764/677Copyright (c) 2021 Revista Brasileira Multidisciplinarhttps://creativecommons.org/licenses/by-nd/4.0info:eu-repo/semantics/openAccessReis Junior, Mauricio AlexandreSanta Rosa, Brunade Santana Reis, JulianaAntônio Corrêa, MarcosGaldorfini Chiari-Andréo, Brunados Santos, Jean LeandroBorges Isaac, Vera Lucia2021-06-29T20:04:08Zoai:ojs.revistarebram.com:article/764Revistahttp://revistarebram.com/index.php/revistauniaraPRIhttps://revistarebram.com/index.php/revistauniara/oairevistauniara@uniara.com||2527-26752527-2675opendoar:2021-06-29T20:04:08Revista Brasileira Multidisciplinar - Universidade de Araraquara (UNIARA)false
dc.title.none.fl_str_mv EFFICACY AND SAFETY OF INNOVATIVE SUNSCREEN (E) -4- (TERT-BUTYL) -N '- ((E) -3- (4-METHOXYPHENYL) ALLYLIDENE) BENZIDRAZIDA (TBMAB)
Efficacy and safety of innovative sunscreen (e) -4- (tert-butyl) -n '- ((e) -3- (4-methoxyphenyl) allylidene) benzidrazida (TBMAB)
title EFFICACY AND SAFETY OF INNOVATIVE SUNSCREEN (E) -4- (TERT-BUTYL) -N '- ((E) -3- (4-METHOXYPHENYL) ALLYLIDENE) BENZIDRAZIDA (TBMAB)
spellingShingle EFFICACY AND SAFETY OF INNOVATIVE SUNSCREEN (E) -4- (TERT-BUTYL) -N '- ((E) -3- (4-METHOXYPHENYL) ALLYLIDENE) BENZIDRAZIDA (TBMAB)
Reis Junior, Mauricio Alexandre
skin cancer
cytotoxicity
UV filters
sunscreen.
title_short EFFICACY AND SAFETY OF INNOVATIVE SUNSCREEN (E) -4- (TERT-BUTYL) -N '- ((E) -3- (4-METHOXYPHENYL) ALLYLIDENE) BENZIDRAZIDA (TBMAB)
title_full EFFICACY AND SAFETY OF INNOVATIVE SUNSCREEN (E) -4- (TERT-BUTYL) -N '- ((E) -3- (4-METHOXYPHENYL) ALLYLIDENE) BENZIDRAZIDA (TBMAB)
title_fullStr EFFICACY AND SAFETY OF INNOVATIVE SUNSCREEN (E) -4- (TERT-BUTYL) -N '- ((E) -3- (4-METHOXYPHENYL) ALLYLIDENE) BENZIDRAZIDA (TBMAB)
title_full_unstemmed EFFICACY AND SAFETY OF INNOVATIVE SUNSCREEN (E) -4- (TERT-BUTYL) -N '- ((E) -3- (4-METHOXYPHENYL) ALLYLIDENE) BENZIDRAZIDA (TBMAB)
title_sort EFFICACY AND SAFETY OF INNOVATIVE SUNSCREEN (E) -4- (TERT-BUTYL) -N '- ((E) -3- (4-METHOXYPHENYL) ALLYLIDENE) BENZIDRAZIDA (TBMAB)
author Reis Junior, Mauricio Alexandre
author_facet Reis Junior, Mauricio Alexandre
Santa Rosa, Bruna
de Santana Reis, Juliana
Antônio Corrêa, Marcos
Galdorfini Chiari-Andréo, Bruna
dos Santos, Jean Leandro
Borges Isaac, Vera Lucia
author_role author
author2 Santa Rosa, Bruna
de Santana Reis, Juliana
Antônio Corrêa, Marcos
Galdorfini Chiari-Andréo, Bruna
dos Santos, Jean Leandro
Borges Isaac, Vera Lucia
author2_role author
author
author
author
author
author
dc.contributor.author.fl_str_mv Reis Junior, Mauricio Alexandre
Santa Rosa, Bruna
de Santana Reis, Juliana
Antônio Corrêa, Marcos
Galdorfini Chiari-Andréo, Bruna
dos Santos, Jean Leandro
Borges Isaac, Vera Lucia
dc.subject.por.fl_str_mv skin cancer
cytotoxicity
UV filters
sunscreen.
topic skin cancer
cytotoxicity
UV filters
sunscreen.
description The constant or repeated unprotected exposure to solar radiation can result in the onset of various harmful effects, such as inflammation, genetic mutation and hyperpigmentation, even than previous photoaging. The use of photoprotective formulations is one of the most effective tools to avoid this. However, most of the UV filters are unstable to UV radiation, can even permeate the skin and cause hepatotoxic effects. The aim of this study was to assess the efficacy and safety of a innovative sunscreen substance (E) -4- (tert-butyl) -N '- ((E) -3- (4-methoxyphenyl) allylidene) benzhydrazide. Methodology: The sunscreen formulation containing the innovative substance was subjected to various stress conditions: 45±2° C, 5±2° C and exposure to sunlight. These samples were evaluated in relation to its rheology, pH, viscosity, density and SPF to determine its stability. The assessment of TBMAB release from the formulation was performed in Microette equipment. Hepatoma cells (HepG2) were used to determine the TBMAB cytotoxicity. Results and Discussion: In the stability study, no significant changes were observed in the formulation. The maximum concentration of TBMAB released from the formulation was 3.63 µg.cm-2. Also, it was evident the cytotoxic effect on the concentrations well above 3.63 µg.cm-2,displaying the safety of this substance, considering HepG2 cells. Conclusion: These results demonstrate that TBMAB is a suitable innovative substance to be used in suscreens, exhibiting stability, desired SPF value and safety, considering HepG2 cells. Thus, it could be a new alternative to prevent skin cancer.  
publishDate 2021
dc.date.none.fl_str_mv 2021-01-10
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://revistarebram.com/index.php/revistauniara/article/view/764
10.25061/2527-2675/ReBraM/2021.v24i1.764
url http://revistarebram.com/index.php/revistauniara/article/view/764
identifier_str_mv 10.25061/2527-2675/ReBraM/2021.v24i1.764
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv http://revistarebram.com/index.php/revistauniara/article/view/764/677
dc.rights.driver.fl_str_mv Copyright (c) 2021 Revista Brasileira Multidisciplinar
https://creativecommons.org/licenses/by-nd/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2021 Revista Brasileira Multidisciplinar
https://creativecommons.org/licenses/by-nd/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Revista Brasileira Multidisciplinar - ReBraM
publisher.none.fl_str_mv Revista Brasileira Multidisciplinar - ReBraM
dc.source.none.fl_str_mv Revista Brasileira Multidisciplinar - ReBraM; v. 24 n. 1 (2021): Janeiro-Abril; 22-32
2527-2675
1415-3580
reponame:Revista Brasileira Multidisciplinar
instname:Universidade de Araraquara (UNIARA)
instacron:UNIARA
instname_str Universidade de Araraquara (UNIARA)
instacron_str UNIARA
institution UNIARA
reponame_str Revista Brasileira Multidisciplinar
collection Revista Brasileira Multidisciplinar
repository.name.fl_str_mv Revista Brasileira Multidisciplinar - Universidade de Araraquara (UNIARA)
repository.mail.fl_str_mv revistauniara@uniara.com||
_version_ 1797174606777286656